Narcolepsy Drugs Market Analysis with Size, Manufacturers, Applications and Forecast Research Report
According to a new report published by KD
Market Insights, titled, "Narcolepsy
Drugs Market by Type, Application, and Drug
Formulation: Global Opportunity Analysis and Industry Forecast, 2019 - 2026,"
The global narcolepsy drugs market generated $2,429 million in 2018, and is
projected to reach $5,360 million by 2026, growing at a CAGR of 10.3% from
2019 to 2026. The electroencephalography devices segment accountead for more
than one-fifth of the total market share in 2017.
Narcolepsy is a chronic disabling condition
with symptoms such as cataplexy, excessive daytime sleepiness (EDS), sleep
paralysis, hypnogogic hallucinations, and disrupted nocturnal sleep. Most of
the narcolepsy drugs are used to treat symptoms related to cataplexy and
excessive daytime sleepiness.
The global narcolepsy drug market size has
witnessed significant growth in the past few years, owing to rise in awareness
regarding the benefits of early diagnosis of narcolepsy drug and availability
of wide variety of narcolepsy drugs contribute toward the market growth.
Governments of countries such as India and South Africa are promoting the
awareness of importance of narcolepsy, which is further expected to boost the
narcolepsy drug market growth during the forecast period. However, stringent
government regulations toward the approval for novel narcolepsy drugs is
projected to hamper the market growth during the forecast period. Conversely,
untapped markets in the developing countries are expected to offer remunerative
opportunities for the market players in the near future.
Based on narcolepsy disease type, the
narcolepsy drugs market is segmented into daytime extreme sleepiness,
cataplexia, and others. Daytime extreme sleepiness segment is the highest
revenue generator in the overall narcolepsy drugs market, as large number of
people suffering from narcolepsy and other sleep disorders have a higher risk
of this symptom, thus increasing the demand for narcolepsy drugs. However, the
cataplexia segment is expected to grow at the highest rate, as patients
suffering from cataplexia experience loss of muscle control, and almost 70% of
narcolepsy patients are found to have this symptom.
Based on therapeutics type, the narcolepsy
drugs market is segmented into central nervous system stimulants, tricyclic
antidepressants, sodium oxybate, selective serotonin reuptake inhibitor, and
others. The sodium oxybate segment held the highest share global narcolepsy
drugs market in the 2018, as these drugs are highly effective to treat daytime
extreme sleepiness and cataplexy. However, selective serotonin reuptake
inhibitor segment is expected to grow at the highest rate due to increase in
R&D activities for the development of these type of drugs by the key
players.
Comprehensive competitive analysis and
profiles of major market players such as Ligand Pharmaceuticals, Addrenex
Pharmaceuticals, Shire Plc, Teva Pharmaceutical Industries Ltd., Arena
Pharmaceuticals, Jazz Pharmaceuticals Plc, Bioprojet, and Novartis have been
provided in this report.
Key Findings of the Narcolepsy Drugs
Market:
- Based on disease type, the cataplexia
segment is expected to experience rapid growth in the market, and is projected
to grow at a highest CAGR from 2019 to 2026.
- Depending on disease type, the daytime extreme sleepiness segment holds the highest share in 2018, and is anticipated to continue this trend during the forecast period.
- By therapeutics type, the sodium oxybate segment was the major revenue contributor in 2018, and is anticipated to continue this trend during the forecast period.
- Asia-Pacific region is anticipated to grow at high CAGR during the forecast period.
- Depending on disease type, the daytime extreme sleepiness segment holds the highest share in 2018, and is anticipated to continue this trend during the forecast period.
- By therapeutics type, the sodium oxybate segment was the major revenue contributor in 2018, and is anticipated to continue this trend during the forecast period.
- Asia-Pacific region is anticipated to grow at high CAGR during the forecast period.
About Us:
KD Market
Insights is one of the leading providers of market intelligence products
and services. We offer reports on over 10+ industries and update our collection
daily which helps our clients to access database of expert market insights on
global industries, companies, products, and trends.
Our
in-house research experts have a wealth of knowledge in their respective
domains. With KD Market Research, you always have the choice of getting
customized report free of cost (upto 10%). Our support team will help you
customize the report and scope as per your business needs. This ensures that
you are making the right purchase decision. Our clients list includes various
Fortune 500 companies and leading advisory firms.
Contact Us:
KD
Market Insights
90
State Street, Albany,
New
York, USA 12207
+1
(519) 300-1215
Comments
Post a Comment